Literature DB >> 4831439

Tumor hybrid cells: an immunotherapeutic agent.

R Parkman.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4831439     DOI: 10.1093/jnci/52.5.1541

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  In vitro transformation of lymphoid cells by Abelson murine leukemia virus.

Authors:  N Rosenberg; D Baltimore; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

2.  Loss of anti-tumour immunogenicity of a somatic cell hybrid line with increasing subculture.

Authors:  R Favre; Y Carcassonne; G Meyer
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

3.  Semi-allogeneic vaccines and tumor-induced immune tolerance.

Authors:  Jin Yu; Mark S Kindy; Sebastiano Gattoni-Celli
Journal:  J Transl Med       Date:  2009-01-08       Impact factor: 5.531

4.  Semi-allogeneic vaccine for T-cell lymphoma.

Authors:  Jin Yu; Mark S Kindy; Sebastiano Gattoni-Celli
Journal:  J Transl Med       Date:  2007-08-08       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.